Thyroid Function Test Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Prevalence of Thyroid Diseases- The rising cases of cancer is expected to increase the demand for thyroid testing which in turn augments the thyroid function test market growth. Twenty million people are thought to suffer from thyroid illness in America. Furthermore, nearly 13% of Americans will experience a thyroid problem at some point in their lives.
- Growing Consumption of Alcohol– Alcohol has been shown to directly inhibit thyroid function through neurotoxicity and indirectly suppress thyroid function by dampening the response to thyrotropin-releasing hormone. According to the World Health Organization, the incidence of alcohol use disorders among men and women is highest in the European and North American regions, where an estimated 237 million men and 46 million women worldwide suffer from them. In high-income nations, alcohol use disorders are more prevalent.
- Rising Cases of COVID-19– It has been speculated that COVID-19 can cause pre-existing thyroid disease or autoimmune conditions to become active. Worldwide, 6,887,000 deaths from COVID-19, involving 761,402,282 confirmed cases as of March 29, 2023, were reported to the World Health Organization.
- Increasing Instances of Thyroid Cancer- Hashimoto thyroiditis is a type of autoimmune thyroid disease (AITD) that is characterized by the immune system's different cell- and antibody-mediated immunological mechanisms destroying thyroid cells. In people older than six years old, this disease is the most frequent cause of hypothyroidism in the US. In addition, the yearly incidence of Hashimoto's disease is between 0.3 to 1.5 cases per 1,000 persons, with approximately a 2% incidence rate in the US. Women are 10 times more likely than males to have the illness.
- Prevalence of Sedentary Lifestyle among People- One of the main causes of thyroid issues, particularly in metro areas, is an active lifestyle. One of the early signs of thyroid disease is a slow metabolism. The World Health Organization estimates that between 60 and 85% of people worldwide, in both developed and developing nations, sustain sedentary lifestyles. Hence, it is one of the more significant yet unaddressed public health issues of our time.
Challenges
- Trouble In Reading Thyroid Blood Test Results - Results may differ from lab to lab, and even if any visit the same lab, the results may differ from test to test, according to the ATA (anti-thyroid antibodies). Thyroid hormone levels have a tendency to rise at night and fall throughout the day. It's possible for the lab to receive one reading on one occasion and a somewhat higher or lower reading on another. Therefore, it is difficult to interpret the thyroid blood test results.
- Lack of Endocrinologists in Many Areas
- Lack of Medical Reimbursement Policies for Thyroid Disease
Rolling Stock Market: Key Insights
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
9.1% |
Base Year Market Size (2024) |
USD 3.18 billion |
Forecast Year Market Size (2037) |
USD 9.87 billion |
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Thyroid Function Test Market in 2025 is evaluated at USD 3.41 billion.
The global market size was over USD 3.18 billion in 2024 and is anticipated to witness a CAGR of around 9.1%, crossing USD 9.87 billion revenue by 2037.
North America is expected to cross USD 3.75 billion by 2037, driven by rising incidence of thyroid conditions and thyroid cancer.
The major players in the market include Abbott, Quest Diagnostics, Eli Lilly and Company, Autobio Diagnostics Co., Ltd., BioMérieux SA, Danaher Corporation, DiaSorin S, P.A., F. Hoffmann-La Roche Ltd., Qualigen Therapeutics Inc., Thermo Fisher Scientific Inc.